Research output per year
Research output per year
Personal profile
Education/Academic qualification
Regenerative Medicine, Ph.D., Skeletal Disorders, The University of Western Australia
2 Jul 2018 → 1 Sept 2022
Award Date: 1 Sept 2022
Regenerative Medicine, M.Phil., New insights into the role of Methionine199 in the function of Receptor Activator of Nuclear Factor Kappa- B Ligand (RANKL) and bone homeostasis, The University of Western Australia
26 Jan 2016 → 6 May 2018
Award Date: 6 May 2018
School of Public Health, B.Sc., Survey of Staphylococci Contamination on the Two Hospitals’ Environments in Yuexiu District of Guangzhou, Guangdong Pharmaceutical University
1 Sept 2010 → 30 Jun 2014
Award Date: 30 Jun 2014
External positions
Research Assistant, First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University
1 Jul 2014 → 1 Oct 2015
Fingerprint
Dive into the research topics where Heng Qiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Buqi-Tongluo Decoction inhibits osteoclastogenesis and alleviates bone loss in ovariectomized rats by attenuating NFATc1, MAPK, NF-κB signaling
Li, Y., Yuan, J., Deng, W., Li, H., Lin, Y., Yang, J., Chen, K., Qiu, H., Wang, Z., Kuek, V., Wang, D., Zhang, Z., Mai, B., Shao, Y., Kang, P., Qin, Q., Li, J., Guo, H., Ma, Y. & Guo, D. & 12 others, , Jan 2025, In: Chinese Journal of Natural Medicines. 23, 1, p. 90-101 12 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Heme metabolism mediates RANKL-induced osteoclastogenesis via mitochondrial oxidative phosphorylation
Qiu, H., Jin, H., Miao, J., Li , H., Chen, J., Yang, X. R., Chen, X., Mullin, B., Chen, K., Gu, R., Qin, A., Wilson, S. & Xu, J., 1 May 2025, In: Journal of Bone and Mineral Research. 40, 5, p. 639-655 17 p., zjaf040.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))
Chen, D., Ye, Z., Wang, C., Wang, Q., Wang, H., Kuek, V., Wang, Z., Qiu, H., Yuan, J., Kenny, J., Yang, F., He, J., Liu, Y., Wang, G., Zhang, M., Zhang, G., Wang, J., Chen, P. & Xu, J., Nov 2024, In: Pharmacological Research. 209, 107463.Research output: Contribution to journal › Comment/debate › peer-review
1 Citation (Scopus) -
Diffusion-based deep learning method for augmenting ultrastructural imaging and volume electron microscopy
Lu, C., Chen, K., Qiu, H., Chen, X., Chen, G., Qi, X. & Jiang, H., 1 Jun 2024, In: Nature Communications. 15, 1, 14 p., 4677.Research output: Contribution to journal › Article › peer-review
Open Access19 Citations (Scopus) -
ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
Qiu, H., Hosking, C., Rothzerg, E., Samantha, A., Chen, K., Kuek, V., Jin, H., Zhu, S., Vrielink, A., Lim, K., Foley, M. & Xu, J., Feb 2023, In: The Journal of Biological Chemistry. 299, 2, p. 102889 102889.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus)
Prizes
-
-
-
-
AUSTRALIAN GOVERNMENT INTERNATIONAL RESEARCH TRAINING PROGRAM and University Postgraduate Award
Qiu, H. (Recipient), 2 Jul 2018
Prize: Postgraduate Scholarship
-